Publicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (16)

2024

  1. Hectorite/Phenanthroline-Based Nanomaterial as Fluorescent Sensor for Zn Ion Detection: A Theoretical and Experimental Study

    Nanomaterials, Vol. 14, Núm. 10

  2. Kinetic Study and Reaction Mechanism of the Gas-Phase Thermolysis Reaction of Methyl Derivatives of 1,2,4,5-Tetroxane

    Molecules, Vol. 29, Núm. 14

  3. Thixotropic Hydrogels Based on Laponite® and Cucurbituril for Delivery of Lipophilic Drug Molecules

    ChemPlusChem, Vol. 89, Núm. 1

2023

  1. Experimental and Computational Study for the Design of Sulfathiazole Dosage Form with Clay Mineral

    Pharmaceutics, Vol. 15, Núm. 2

2022

  1. Melatonin/nanoclay hybrids for skin delivery

    Applied Clay Science, Vol. 218

2021

  1. Enhanced antimicrobial activity and physicochemical stability of rapid pyro-fabricated silver-kaolinite nanocomposite

    International Journal of Pharmaceutics, Vol. 598

2020

  1. Correlation between elemental composition/mobility and skin cell proliferation of fibrous nanoclay/spring water hydrogels

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-20

  2. Polymer/iron-based layered double hydroxides as multifunctional wound dressings

    Pharmaceutics, Vol. 12, Núm. 11, pp. 1-18

2019

  1. Crosslinked palygorskite-chitosan beads as diclofenac carriers

    Applied Clay Science, Vol. 180

2016

  1. Hybrid systems based on “drug – in cyclodextrin – in nanoclays” for improving oxaprozin dissolution properties

    International Journal of Pharmaceutics, Vol. 509, Núm. 1-2, pp. 8-15

2014

  1. Folk pharmaceutical formulations in western Mediterranean: Identification and safety of clays used in pelotherapy

    Journal of Ethnopharmacology, Vol. 155, Núm. 1, pp. 810-814

2013

  1. Release kinetics of 5-aminosalicylic acid from halloysite

    Colloids and Surfaces B: Biointerfaces, Vol. 105, pp. 75-80

2011

  1. Assessement of anti-inflammatory properties of microspheres prepared with chitosan and 5-amino salicylic acid over inflamed Caco-2 cells

    Carbohydrate Polymers, Vol. 85, Núm. 3, pp. 638-644

2010

  1. Chitosan-silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA)

    Applied Clay Science, Vol. 50, Núm. 1, pp. 106-111

  2. Current challenges in clay minerals for drug delivery

    Applied Clay Science, Vol. 48, Núm. 3, pp. 291-295

2001

  1. Disintegrant efficiency of special phyllosilicates: smectite, palygorskite, sepiolite

    STP PHARMA SCIENCES, Vol. 11, Núm. 2, pp. 137-143